To investigate the role of the GAS6-TYRO3 axis in melanoma progression and its impact on immunotherapy efficacy, we generated myeloid-specific GAS6 knockout (Myeloid-GAS6 KO) mice and established a melanoma model by injecting tumor cells into these mice and wild-type (WT) controls. The gene discussed is TYRO3; the disease is neoplasm.